Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Laura Rosanò, Roberta Cianfrocca, Rosanna Sestito, Piera Tocci, Valeriana Di Castro & Anna Bagnato. (2017) Targeting endothelin-1 receptor/β-arrestin1 network for the treatment of ovarian cancer. Expert Opinion on Therapeutic Targets 21:10, pages 925-932.
Read now
Read now
Laura Rosanò & Anna Bagnato. (2015) Disrupting the endothelin and Wnt relationship to overcome chemoresistance. Molecular & Cellular Oncology 2:3.
Read now
Read now
Articles from other publishers (34)
Francisco Rodas, Jetzabel A. Vidal-Vidal, Daniela Herrera, David A. Brown-Brown, Diego Vera, Joaquín Veliz, Pilar Püschel, José I. Erices, Verónica Sánchez Hinojosa, Julio C. Tapia, Eduardo Silva-Pavez, Claudia Quezada-Monrás, Pablo Mendoza-Soto, Flavio Salazar-Onfray, Cristian Carrasco & Ignacio Niechi. (2023) Targeting the Endothelin-1 pathway to reduce invasion and chemoresistance in gallbladder cancer cells. Cancer Cell International 23:1.
Crossref
Crossref
Ivan Lučić, Matea Kurtović, Monika Mlinarić, Nikolina Piteša, Ana Čipak Čipak Gašparović, Maja Sabol & Lidija Milković. (2023) Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches. International Journal of Molecular Sciences 24:13, pages 10683.
Crossref
Crossref
Ankur Tiwari, Tamas Oravecz, Laura A. Dillon, Antoine Italiano, Laurent Audoly, Wolf Hervé Fridman & Guy Travis Clifton. (2023) Towards a consensus definition of immune exclusion in cancer. Frontiers in Immunology 14.
Crossref
Crossref
Ignacio Niechi, José I. Erices, Diego Carrillo-Beltrán, Atenea Uribe-Ojeda, Ángelo Torres, José Dellis Rocha, Daniel Uribe, María A. Toro, Karla Villalobos-Nova, Belén Gaete-Ramírez, Gabriel Mingo, Gareth I. Owen, Manuel Varas-Godoy, Lilian Jara, Francisco Aguayo, Verónica A. Burzio, Claudia Quezada-Monrás & Julio C. Tapia. (2023) Cancer Stem Cell and Aggressiveness Traits Are Promoted by Stable Endothelin-Converting Enzyme-1c in Glioblastoma Cells. Cells 12:3, pages 506.
Crossref
Crossref
Chrysovalantis Voutouri, Myrofora Panagi, Fotios Mpekris, Andreas Stylianou, Christina Michael, Michalakis A. Averkiou, John D. Martin & Triantafyllos Stylianopoulos. (2021) Endothelin Inhibition Potentiates Cancer Immunotherapy Revealing Mechanical Biomarkers Predictive of Response. Advanced Therapeutics 4:9, pages 2000289.
Crossref
Crossref
Ilenia Masi, Valentina Caprara, Francesca Spadaro, Lidia Chellini, Rosanna Sestito, Andrea Zancla, Alberto Rainer, Anna Bagnato & Laura Rosanò. (2021) Endothelin-1 drives invadopodia and interaction with mesothelial cells through ILK. Cell Reports 34:9, pages 108800.
Crossref
Crossref
Rodrigo Zebadúa, Andrea Priscila Hernández-Pérez, Antonio García, Nayeli Zayas, Julio Sandoval, Julio López & Tomás Pulido. (2021) Macitentan in the treatment of pulmonary arterial hypertension. Future Cardiology 17:1, pages 49-58.
Crossref
Crossref
Georgia Koutsoumpli, Oana Draghiciu, Hans W Nijman, Cesar Oyarce & Toos Daemen. 2021. Cancer Immunology. Cancer Immunology
61
83
.
Frederik C. Enevoldsen, Jayashree Sahana, Markus Wehland, Daniela Grimm, Manfred Infanger & Marcus Krüger. (2020) Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy. Journal of Clinical Medicine 9:3, pages 824.
Crossref
Crossref
Pablo Pérez‐Moreno, Sebastián Indo, Ignacio Niechi, Hernán Huerta, Pablo Cabello, Lilian Jara, Francisco Aguayo, Manuel Varas‐Godoy, Verónica A. Burzio & Julio C. Tapia. (2019) Endothelin‐converting enzyme‐1c promotes stem cell traits and aggressiveness in colorectal cancer cells. Molecular Oncology 14:2, pages 347-362.
Crossref
Crossref
Sara I. Pai, Alessandra Cesano & Francesco M. Marincola. 2020. Tumor Microenvironment. Tumor Microenvironment
173
195
.
Jiri Hatina, Maximilian Boesch, Sieghart Sopper, Michaela Kripnerova, Dominik Wolf, Daniel Reimer, Christian Marth & Alain G. Zeimet. 2019. Stem Cells Heterogeneity in Cancer. Stem Cells Heterogeneity in Cancer
201
221
.
Rossana Maffei, Stefania Fiorcari, Tiziana Vaisitti, Silvia Martinelli, Stefania Benatti, Giulia Debbia, Davide Rossi, Patrizia Zucchini, Leonardo Potenza, Mario Luppi, Gianluca Gaidano, Silvia Deaglio & Roberto Marasca. (2017) Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia. Oncotarget 8:52, pages 90013-90027.
Crossref
Crossref
Roberta Cianfrocca, Laura Rosanò, Piera Tocci, Rosanna Sestito, Valentina Caprara, Valeriana Di Castro, Ruggero De Maria & Anna Bagnato. (2017) Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer. Cell Death & Differentiation 24:10, pages 1811-1820.
Crossref
Crossref
Luwei Wei, Fuqiang Yin, Wei Zhang & Li Li. (2017) STROBE-compliant integrin through focal adhesion involve in cancer stem cell and multidrug resistance of ovarian cancer. Medicine 96:12, pages e6345.
Crossref
Crossref
Laura Rosanò & Anna Bagnato. (2016) β-arrestin1 at the cross-road of endothelin-1 signaling in cancer. Journal of Experimental & Clinical Cancer Research 35:1.
Crossref
Crossref
John-David Aubert & Lucienne Juillerat-Jeanneret. (2016) Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis. Journal of Medicinal Chemistry 59:18, pages 8168-8188.
Crossref
Crossref
Vasile Foris, Gabor Kovacs, Leigh M. Marsh, Zoltán Bálint, Martin Tötsch, Alexander Avian, Philipp Douschan, Bahil Ghanim, Walter Klepetko, Andrea Olschewski & Horst Olschewski. (2016)
CD133
+
cells in pulmonary arterial hypertension
. European Respiratory Journal 48:2, pages 459-469.
Crossref
Crossref
Rosanna Sestito, Roberta Cianfrocca, Laura Rosanò, Piera Tocci, Valeriana Di Castro, Valentina Caprara & Anna Bagnato. (2016) Macitentan blocks endothelin-1 receptor activation required for chemoresistant ovarian cancer cell plasticity and metastasis. Life Sciences 159, pages 43-48.
Crossref
Crossref
E Semprucci, P Tocci, R Cianfrocca, R Sestito, V Caprara, M Veglione, V Di Castro, F Spadaro, G Ferrandina, A Bagnato & L Rosanò. (2015) Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma. Oncogene 35:26, pages 3432-3442.
Crossref
Crossref
Roberta Cianfrocca, Piera Tocci, Laura Rosanò, Valentina Caprara, Rosanna Sestito, Valeriana Di Castro & Anna Bagnato. (2016) Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression. Oncotarget 7:14, pages 17790-17804.
Crossref
Crossref
Laura Rosanò & Anna Bagnato. (2016) Endothelin therapeutics in cancer: Where are we?. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 310:6, pages R469-R475.
Crossref
Crossref
Lan G. Coffman, Yun-Jung Choi, Karen McLean, Benjamin L. Allen, Marina Pasca di Magliano & Ronald J. Buckanovich. (2016)
Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance
via
a BMP4/HH signaling loop
. Oncotarget 7:6, pages 6916-6932.
Crossref
Crossref
Rosanna Sestito, Roberta Cianfrocca, Laura Rosanò, Piera Tocci, Elisa Semprucci, Valeriana Di Castro, Valentina Caprara, Gabriella Ferrandina, Andrea Sacconi, Giovanni Blandino & Anna Bagnato. (2015) miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma. Oncotarget 7:4, pages 4009-4023.
Crossref
Crossref
Z.L. Neumann, H.C. Pondenis, A. Masyr, M.L. Byrum, K.L. Wycislo & T.M. Fan. (2015) The Association of Endothelin‐1 Signaling with Bone Alkaline Phosphatase Expression and Protumorigenic Activities in Canine Osteosarcoma. Journal of Veterinary Internal Medicine 29:6, pages 1584-1594.
Crossref
Crossref
Youssef A. Rezk, Kun Yang, Shoumei Bai, Karen Mclean, Carolyn Johnston, R. Kevin Reynolds & Ronald J. Buckanovich. (2015) Disulfiram’s Antineoplastic Effects on Ovarian Cancer. Journal of Cancer Therapy 06:14, pages 1196-1205.
Crossref
Crossref
Laura Rosanò, Roberta Cianfrocca, Piera Tocci, Francesca Spinella, Valeriana Di Castro, Valentina Caprara, Elisa Semprucci, Gabriella Ferrandina, Pier Giorgio Natali & Anna Bagnato. (2014) Endothelin A Receptor/β-Arrestin Signaling to the Wnt Pathway Renders Ovarian Cancer Cells Resistant to Chemotherapy. Cancer Research 74:24, pages 7453-7464.
Crossref
Crossref
Hui Zhang, Xinping Gao, Yongan Yang, Weiming Wang, Jin Liu, Yijuan Liang, Hongli Wu, Jinjin Qin, Kun Pan, Yifeng Wang, Junrong Shi & Youju Ma. (2014) New construction of an animal model for the orthotopic transplantation of an ovarian tumor. Journal of Ovarian Research 7:1.
Crossref
Crossref
Luis Fernando Tume Farfán. (2014) La inmunoterapia en la búsqueda de antígenos contra las células madre del cáncer. Inmunología 33:3, pages 96-109.
Crossref
Crossref
Irene S. Hong, Holly V. Coe & Linda M. Catanzaro. (2014) Macitentan for the Treatment of Pulmonary Arterial Hypertension. Annals of Pharmacotherapy 48:4, pages 538-547.
Crossref
Crossref
Jaeyoung Lim, Kun Yang, Barbie Taylor-Harding, W. Ruprecht Wiedemeyer & Ronald J. Buckanovich. (2014) VEGFR3 Inhibition Chemosensitizes Ovarian Cancer Stemlike Cells through Down-Regulation of BRCA1 and BRCA2. Neoplasia 16:4, pages 343-353.e2.
Crossref
Crossref
Laura Rosanò, Francesca Spinella & Anna Bagnato. (2013) Endothelin 1 in cancer: biological implications and therapeutic opportunities. Nature Reviews Cancer 13:9, pages 637-651.
Crossref
Crossref
Mirjana Kessler, Christina Fotopoulou & Thomas Meyer. (2013) The Molecular Fingerprint of High Grade Serous Ovarian Cancer Reflects Its Fallopian Tube Origin. International Journal of Molecular Sciences 14:4, pages 6571-6596.
Crossref
Crossref
Mariana Bianchi, Javier Adur, Maria F. Izaguirre, Silvia Viale, Carlos L. Cesar & Víctor H. Casco. (2013) Endothelin-2 Differential Expression in Normal and Early-Stages of Colon Cancer Development. Journal of Cancer Therapy 04:06, pages 26-33.
Crossref
Crossref